ArticleMolecular therapy : the journal of the American Society of Gene Therapy2009

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM.

James M Markert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.